259 related articles for article (PubMed ID: 27793695)
1. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
[TBL] [Abstract][Full Text] [Related]
2. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer.
Zheng CH; Wang JB; Lin MQ; Zhang PY; Liu LC; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Xie JW; Li P; Huang CM
J Exp Clin Cancer Res; 2018 Mar; 37(1):59. PubMed ID: 29540196
[TBL] [Abstract][Full Text] [Related]
3. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
5. Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.
Kundu J; Wahab SM; Kundu JK; Choi YL; Erkin OC; Lee HS; Park SG; Shin YK
Int J Oncol; 2012 Sep; 41(3):839-48. PubMed ID: 22710759
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.
Shi R; Yang Z; Liu W; Liu B; Xu Z; Zhang Z
Oncol Rep; 2014 Feb; 31(2):812-8. PubMed ID: 24297051
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
[TBL] [Abstract][Full Text] [Related]
8. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
9. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
[TBL] [Abstract][Full Text] [Related]
11. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling.
Feng X; Jiang J; Sun L; Zhou Q
Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
Chen L; Xu M; Zhong W; Hu Y; Wang G
Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
[TBL] [Abstract][Full Text] [Related]
14. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
15. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
16. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
17. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway.
Pan J; Fan Z; Wang Z; Dai Q; Xiang Z; Yuan F; Yan M; Zhu Z; Liu B; Li C
J Exp Clin Cancer Res; 2019 Feb; 38(1):52. PubMed ID: 30717785
[TBL] [Abstract][Full Text] [Related]
18. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
[TBL] [Abstract][Full Text] [Related]
19. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
[TBL] [Abstract][Full Text] [Related]
20. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]